Elimination of Piperacillin and Tazobactam by Renal Replacement Therapies with AN69 and Polysulfone Hemofilters: Evaluation of the Sieving Coefficient-Reference-Cited by-同舟云学术

Elimination of Piperacillin and Tazobactam by Renal Replacement Therapies with AN69 and Polysulfone Hemofilters: Evaluation of the Sieving Coefficient

Published:2006 Issue:4 Volume:24 Page:347-354
ISSN:0253-5068
Container-title:Blood Purification
language:en
Short-container-title:Blood Purif

Author:

Arzuaga A.,Isla A.,Gascón A.R.,Maynar J.,Corral E.,Pedraz J.L.

Publisher

S. Karger AG

Subject

Nephrology,Hematology,General Medicine

Reference42 articles.

1. Piperacillin/Tazobactam

2. Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children

3. Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia

4. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates

5. The effect of piperacillin dose on elimination kinetics in renal impairment

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy;BMC Nephrology;2024-02-27

2. Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model againstKlebsiella pneumoniae—authors’ response;Journal of Antimicrobial Chemotherapy;2023-01-30

3. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature;Clinical Pharmacokinetics;2021-11-30

4. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients;Antimicrobial Agents and Chemotherapy;2017-08

5. Boliden auf der Intensivstation;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2017-05-08